Page last updated: 2024-12-11

bongkrekic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bongkrekic Acid: An antibiotic produced by Pseudomonas cocovenenans. It is an inhibitor of MITOCHONDRIAL ADP, ATP TRANSLOCASES. Specifically, it blocks adenine nucleotide efflux from mitochondria by enhancing membrane binding. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bongkrekic acid : A tricarboxylic acid that is docosa-2,4,8,10,14,18,20-heptaenedioic acid substituted at positions 2 ,5 and 17 by methyl groups, at positions 6 by a methoxy group and at position 20 by a carboxymethyl group. It is produced by the bacterium Burkholderia gladioli and implicated in outbreaks of food-borne illness involving coconut and corn-based products in Indonesia and China. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6433556
CHEBI ID77742
SCHEMBL ID98556
MeSH IDM0002799

Synonyms (25)

Synonym
2,4,8,10,14,18,20-docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (r-(r*,s*-(e,z,z,e,e,z,e)))-
flavotoxin a
3-carboxymethyl-17-methoxy-6,18,21-trimethyldocosa-2,4,8,12,14,18,20-heptaenedioic acid
2,4,8,10,14,18,20-docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (r-(r*,s*(e,z,z,e,e,z,e)))-
bongkrekic acid
(2e,4z,6r,8z,10e,14e,17s,18e,20z)-20-(carboxymethyl)-6-methoxy-2,5,17-trimethyldocosa-2,4,8,10,14,18,20-heptaenedioic acid
gtpl4689
11076-19-0
94188-24-6
unii-l7v4i673d2
hsdb 8497
l7v4i673d2 ,
BKC ,
SCHEMBL98556
CHEBI:77742
(-)-bongkrekic acid
2,4,8,10,14,18,20-docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (2e,4z,6r,8z,10e,14e,17s,18e,20z)-
bongkrekic acid [mi]
bongkreksaure
DTXSID00894840
HY-136406
CS-0129190
isobongkrekic acid,
(2e,4z,6r,8z,10e,14e,17s,18e,20z)-20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-2,4,8,10,14,18,20-docosaheptaenedioic acid
AKOS040755025

Research Excerpts

Overview

Bongkrekic acid (BKA) is a natural toxin isolated from coconut tempeh contaminated with the bacterium Burkholderia cocovenans. It is a mitochondrial ANT toxin and is reported primarily in outbreaks of food-borne poisoning involving coconut and corn.

ExcerptReferenceRelevance
"Bongkrekic acid (BKA) is a natural toxin isolated from coconut tempeh contaminated with the bacterium Burkholderia cocovenans."( Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells.
Aramaki, H; Himeno, T; Kakizoe, K; Kudo, T; Matsumoto, K; Okazaki, H; Shindo, M; Takeda, S, 2016
)
2.6
"Bongkrekic acid is a heat-stable, highly unsaturated tricarboxylic fatty acid with a molecular weight of 486 kDa."( Bongkrekic Acid-a Review of a Lesser-Known Mitochondrial Toxin.
Anwar, M; Kasper, A; Schier, JG; Steck, AR, 2017
)
2.62
"Bongkrekic acid is a mitochondrial ANT toxin and is reported primarily in outbreaks of food-borne poisoning involving coconut and corn. "( Bongkrekic Acid-a Review of a Lesser-Known Mitochondrial Toxin.
Anwar, M; Kasper, A; Schier, JG; Steck, AR, 2017
)
3.34
"Bongkrekic acid (BKA) is an inhibitor of adenine nucleotide translocase (ANT). "( Molecular design, synthesis, and evaluation of novel potent apoptosis inhibitors inspired from bongkrekic acid.
Abe, M; Hasui, K; Matsumoto, K; Okuda, K; Shindo, M, 2012
)
2.04
"Bongkrekic acid (BKA) is a chemical that functions as a ligand of the adenine nucleotide translocator and is known to potently inhibit the mitochondrial permeability transition that is associated with apoptosis."( Mitochondrial delivery of bongkrekic acid using a MITO-Porter prevents the induction of apoptosis in human HeLa cells.
Furukawa, R; Harashima, H; Kawamura, E; Matsumoto, K; Moriwaki, T; Nakamura, K; Okuda, K; Shindo, M; Yamada, Y, 2013
)
1.41

Effects

ExcerptReferenceRelevance
"Bongkrekic acid (BA) has a unique mechanism of toxicity among the mitochondrial toxins: it inhibits adenine nucleotide translocase (ANT) rather than the electron transport chain. "( Bongkrekic Acid-a Review of a Lesser-Known Mitochondrial Toxin.
Anwar, M; Kasper, A; Schier, JG; Steck, AR, 2017
)
3.34
"Bongkrekic acid (BA) has a unique mechanism of toxicity among the mitochondrial toxins: it inhibits adenine nucleotide translocase (ANT) rather than the electron transport chain. "( Bongkrekic Acid-a Review of a Lesser-Known Mitochondrial Toxin.
Anwar, M; Kasper, A; Schier, JG; Steck, AR, 2017
)
3.34

Compound-Compound Interactions

ExcerptReferenceRelevance
" Combined with the clinical records, we found that the difference in blood glucose between the deceased and survivors of the five victims may be an indication of the severity of the disease."( Bongkrekic acid poisoning: Severe liver function damage combined with multiple organ failure caused by eating spoiled food.
Chen, Y; Dai, Y; Gao, Y; Huang, Q; Liu, S; Long, C; Luo, B; Ma, Q; Quan, L; Shi, R; Zhang, N; Zhang, Y, 2019
)
1.96
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
apoptosis inhibitorAny substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
EC 2.5.1.18 (glutathione transferase) inhibitorAn EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of a glutathione transferase (EC 2.5.1.18).
toxinPoisonous substance produced by a biological organism such as a microbe, animal or plant.
ATP/ADP translocase inhibitorAny inhibitor of the trasporter protein ATP/ADP translocase.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (264)

TimeframeStudies, This Drug (%)All Drugs %
pre-199076 (28.79)18.7374
1990's38 (14.39)18.2507
2000's98 (37.12)29.6817
2010's42 (15.91)24.3611
2020's10 (3.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.25 (24.57)
Research Supply Index5.58 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index118.82 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (69.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (2.26%)6.00%
Case Studies4 (1.51%)4.05%
Observational0 (0.00%)0.25%
Other255 (96.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]